AI trial to tackle breast cancer launched

Nearly 700,000 women across the country will take part in a trial to test how AI tools can be used to catch breast cancer cases earlier, the DHSC has announced.

© National Cancer Institute/Unsplash

© National Cancer Institute/Unsplash

Under the plans, 30 testing sites across the country will be enhanced with the latest digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part.

The technology will assist radiologists, screening patients to identify changes in breast tissue that show possible signs of cancer and referred for further investigations if required.

Currently two specialists are needed per mammogram screening, but this technology will enable just one to complete the same mammogram screening process safely and efficiently.

The EDITH trial is backed by £11m of government support via the National Institute for Health and Care Research (NIHR).

Prof Lucy Chappell, chief scientific adviser at the DHSC and chief executive of the NIHR, said: ‘This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most. 

‘It is another example of how NIHR research, shaped and funded by the public, is crucial for rigorously testing world-leading new technologies, such as AI, that can potentially save lives while reducing the burden on the NHS.'

Government invests £20m in faster AI cancer diagnosis

Government invests £20m in faster AI cancer diagnosis

By Lee Peart 11 June 2026

The Government is investing £20m in rolling out AI-powered X-ray tools that provide faster cancer diagnosis to all NHS trusts by 2029.

EXCLUSIVE: NHS heroes recognised after accelerating cancer diagnosis and transforming patient care

By Lee Peart 11 June 2026

Groundbreaking NHS teams that have freed up thousands of hospital beds, accelerated cancer diagnosis and transformed care for patients have been recognised a...

Men with early prostate cancer to be offered precision radiotherapy

By Lee Peart 10 June 2026

A high-powered ‘precision’ radiotherapy known as SABR (stereotactic ablative radiotherapy) is to be offered to eligible men with early prostate cancer for th...


Popular articles by Liz Wells